Loss of TRIM24 promotes IL-10 expression via CBP/p300-dependent IFNβ1 transcription during macrophage activation
- 16 June 2023
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 72 (7) , 1441-1452
Abstract
Background As an anti-inflammatory cytokine, interleukin 10 (IL-10) plays a vital role in preventing inflammatory and autoimmune pathologies while also maintaining immune homeostasis. IL-10 production in macrophages is tightly regulated by multiple pathways. TRIM24, a member of the Transcriptional Intermediary Factor 1 (TIF1) family, contributes to antiviral immunity and macrophage M2 polarization. However, the role of TRIM24 in regulating IL-10 expression and its involvement in endotoxic shock remains unclear. Methods In vitro, bone marrow derived macrophages cultured with GM-CSF or M-CSF were stimulated with LPS (100ng/ml). Murine models of endotoxic shock were established by challenging the mice with different dose of LPS (i.p). RTPCR, RNA sequencing, ELISA and hematoxylin and eosin staining were performed to elucidate the role and mechanisms of TRIM24 in endotoxic shock. Results The expression of TRIM24 is downregulated in LPS-stimulated bone marrow-derived macrophages (BMDMs). Loss of TRIM24 boosted IL-10 expression during the late stage of LPS-stimulation in macrophages. RNA-seq analysis revealed the upregulation of IFNβ1, an upstream regulator of IL-10, in TRIM24 knockout macrophages. Treatment with C646, a CBP/p300 inhibitor, diminished the difference in both IFNβ1 and IL-10 expression between TRIM24 knockout and control macrophages. Loss of TRIM24 provided protection against LPS-induced endotoxic shock in mice. Conclusion Our results demonstrated that inhibiting TRIM24 promoted the expression of IFNβ1 and IL-10 during macrophage activation, therefore protecting mice from endotoxic shock. This study offers novel insights into the regulatory role of TRIM24 in IL-10 expression, making it a potentially attractive therapeutic target for inflammatory diseases.Keywords
Funding Information
- National Natural Science Foundation of China (31900638, 31970555, 32100477, 32070630)
- the University-level scientific research project of Ningxia Medical University (XT2022006)
- National Key R&D Project of China (2018YFA0800102)
- Zhejiang Innovation Team Grant (2020R01006)
This publication has 48 references indexed in Scilit:
- Local Increase of Arginase Activity in Lesions of Patients with Cutaneous Leishmaniasis in EthiopiaPLOS Neglected Tropical Diseases, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinomaProceedings of the National Academy of Sciences, 2011
- Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and FibrosisPLOS Pathogens, 2009
- The Isolation and Characterization of Murine MacrophagesCurrent Protocols in Immunology, 2008
- Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogensNature Immunology, 2008
- SOAP: short oligonucleotide alignment programBioinformatics, 2008
- TLR signalingCell Death & Differentiation, 2006
- Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.Journal of Clinical Investigation, 1995